
Reliance Industries and Capri Global Holdings are set to acquire Mumbai’s 1,500-bed SevenHills Hospital, bringing an end to a prolonged insolvency dispute that has lasted for nearly 8 years, as per The Economic Times report.
The acquisition follows approval by the National Company Law Tribunal of a corporate insolvency resolution plan submitted by Capri Global, backed by equity support from the Mukesh Ambani-owned Reliance Group.
Under the approved plan, secured lenders will recover ₹449 crore, representing around 40% of their admitted claims. The Municipal Corporation of Greater Mumbai will receive a settlement amount of ₹223.4 crore along with approximately ₹205 crore towards other dues, while employees and operational creditors will be paid ₹6 crore.
The transaction will be executed through a multi-step scheme of arrangement. Reliance Group and Capri Global will jointly infuse funds through equity, quasi-equity or shareholder debt, potentially via a special purpose vehicle.
On the effective date, the partners will subscribe to 10 million new shares for ₹10 crore, after which all existing shares will be cancelled for zero consideration, resulting in equal ownership between the 2 entities.
A subsequent scheme will convert SevenHills Healthcare into a not-for-profit entity, with the Reliance Foundation Hospital Trust replacing all earlier guarantors. This structure will allow any surplus generated by the hospital to be fully reinvested into healthcare infrastructure and services.
Capri Global’s bid was unanimously approved by lenders as it secured the mandatory no-objection certificate from MCGM, a requirement introduced after a 2019 ruling by the Supreme Court of India.
An earlier resolution plan by New Medical Centre had been overturned after the civic body opposed it. The hospital, which operates on land owned by MCGM, has also faced disputes over unpaid rent of ₹140.8 crore.
With the new plan in place, the long-running deadlock over SevenHills Hospital’s future is expected to finally be resolved.
Read More: Reliance Industries Share Price in Focus; Denies Claims of Russian Oil Shipments to Jamnagar Refinery!
As of January 29, 2026, at 10:01 AM, Reliance Industries share price is trading at ₹1,389.80 per share, reflecting a decline of 0.49% from the previous closing price. Over the past month, the stock has declined by 10.08%.
The NCLT approval brings closure to a long-running insolvency process, ensuring partial recovery for lenders and settlement of civic dues. With equity backing and not-for-profit conversion, the acquisition aims to stabilise SevenHills Hospital while enabling reinvestment into healthcare infrastructure and public health services in Mumbai.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 29, 2026, 11:48 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
